Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
40 studies found for:    " December 23, 2009":" January 22, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Completed Preventative Misconception Intervention
Conditions: HIV;   HIV Infections
Interventions: Behavioral: 1-sided messages;   Behavioral: 2-sided messages
2 Completed Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
Conditions: HIV Infection;   HIV Infections
Intervention: Genetic: SB-728-T
3 Completed HIV Treatment and CVD Events
Conditions: HIV Infection;   Cardiovascular Disease;   Infection, Human Immunodeficiency Virus;   Acute Myocardial Infarction
Intervention: Drug: HAART Treatment
4 Completed Treatment for Depression Among HIV-Infected Youth
Conditions: HIV;   Depression;   HIV Infections
Interventions: Behavioral: COMB - Combination Cognitive Behavioral Therapy and Medication Management;   Behavioral: TAU - Treatment as Usual
5 Completed Cell Phone Reminders Intervention
Conditions: HAART Non-Adherence;   HIV;   HIV Infections
Intervention: Behavioral: Cell Phone Intervention
6 Unknown  A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance
Conditions: HIV;   HIV Infections
Intervention: Drug: Raltegravir
7 Completed High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk
Conditions: HIV-related Lymphoma;   HIV Infections
Intervention: Other: Rituximab and CHOP regimen + PBSCT
8 Terminated Pre-Exposure Prophylaxis Using TMC278LA
Condition: HIV Infections
Intervention: Drug: TMC278LA
9 Completed TMC114-TiDP3-C182 - A Study to Compare the Oral Bioavailability of a 800 mg Prototype Tablet Formulation of Darunivar (DRV) to That of the 400 mg Commercial Tablet Formulation in the Presence of Low Dose Ritonavir, Under Fasted and Fed Conditions
Condition: HIV Infections
Intervention: Drug: DRV commercial formulation/ DRV new formulation/ rtv 100mg tab
10 Completed Examining the Role of Genetics in Determining the Immune Response to an HIV Vaccine in HIV-Uninfected Adult Twins
Condition: HIV Infections
Interventions: Biological: HIV-1 DNA plasmid vaccine;   Biological: HIV-1 recombinant Ad5 vaccine
11 Terminated Impact of Maraviroc on the Immune Function in HIV-1 Infected Subjects Receiving Immunisation With Novel Antigens
Condition: HIV Infections
Interventions: Drug: Maraviroc;   Drug: placebo
12 Completed Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status
Condition: HIV Infections
Interventions: Drug: Emtricitabine (FTC);   Drug: Tenofovir disoproxil fumarate (TDF);   Drug: Efavirenz (EFV);   Drug: Truvada
13 Completed
Has Results
Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria
Conditions: HIV Infections;   Proteinuria
Intervention: Drug: change from tenofovir to raltegravir
14 Completed Effect Of Maraviroc On The Pharmacokinetics Of Digoxin
Conditions: Healthy;   HIV Infections
Interventions: Drug: Digoxin;   Drug: Maraviroc
15 Active, not recruiting Investigator-Sponsored Protocol - Continued Use of Ibalizumab
Condition: HIV Infections
Intervention: Drug: ibalizumab
16 Completed Telephone Based Cognitive Behavioral Therapy for HIV Related Depression
Conditions: Depression;   HIV Infections
Interventions: Behavioral: Telephone-based CBT;   Behavioral: Enhanced Usual Care
17 Completed Establishing Effectiveness of Daily Co-trimoxazole Prophylaxis For Prevention of Malaria in Pregnancy
Conditions: Malaria in Pregnancy;   HIV Infections
Interventions: Drug: Cotrimoxazole prophylaxis;   Drug: SP IPT
18 Completed MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use
Conditions: Acne Vulgaris;   Allergic Rhinitis;   Anxiety;   Asthma;   Back Pain;   Prostatic Hyperplasia;   Bursitis;   Chronic Obstructive Pulmonary Disease;   Cough;   Coronary Artery Disease;   Depression;   Diabetes Mellitus;   Diarrhea;   Gastroesophageal Reflux;   Fibromyalgia;   Headache;   HIV Infections;   Hypothyroidism;   Hyperlipidemia;   Hypertension;   Influenza;   Sleep Initiation and Maintenance Disorders;   Irritable Bowel Syndrome;   Migraine Disorders;   Obesity;   Obstructive Sleep Apnea;   Osteoarthritis;   Senile Osteoporosis;   Shoulder Pain;   Sinusitis;   Smoking Cessation;   Tobacco Use Cessation;   Menopause;   Urinary Incontinence;   Urinary Tract Infection;   Vaginitis;   Vertigo
Intervention: Other: health information prescription
19 Unknown  Lopinavir/Ritonavir or Efavirenz as First-line Antiretroviral Therapy
Condition: HIV Infections
Intervention: Drug: First-line Antiretroviral Therapy
20 Completed
Has Results
Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: ARV (non-raltegravir)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years